ABUS — Arbutus Biopharma Corp stock price, charts and financials

QT70Arbutus Biopharma Corp

Arbutus Biopharma Corp (NASDAQ: ABUS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.01
-0.06-1.18%
OverviewShort InterestFilings
ABUSQT70Arbutus Biopharma Corp·NASDAQ
5.01-1.18%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 04, 2026SC 13GBeneficial ownership statement (passive)
Aug 24, 2026SC TO-IIssuer tender offer statement
Aug 21, 2026SC TO-CSC TO-C
Aug 21, 20268-KCurrent report
Aug 12, 202610-QQuarterly report
Aug 12, 20268-KCurrent report
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 16, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 05, 2026S-8Registration of employee benefit securities
May 27, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 202610-QQuarterly report
May 13, 20268-KCurrent report
Apr 28, 2026SC 13D/ABeneficial ownership statement (active, amended)
Apr 15, 20268-KCurrent report
Apr 14, 2026DEF 14ADefinitive proxy statement
Apr 14, 2026DEFA14AAdditional proxy soliciting materials
Apr 13, 2026SC 13D/ABeneficial ownership statement (active, amended)
Mar 23, 202610-KAnnual report
Mar 23, 20268-KCurrent report
Mar 03, 20268-KCurrent report
Feb 20, 20268-KCurrent report
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 240
Page
▼
/ 10